Sermet-Gaudelus I - Search Results

1

Systemic bis-phosphinic acid derivative restores chloride transport in Cystic Fibrosis mice.

da Cunha MF, Pranke I, Sassi A, Schreiweis C, Moriceau S, Vidovic D, Hatton A, Carlon MS, Creste G, Berhal F, Prestat G, Freund R, Odolczyk N, Jais JP, Gravier-Pelletier C, Zielenkiewicz P, Jullien V, Hinzpeter A, Oury F, Edelman A, Sermet-Gaudelus I. da Cunha MF, et al. Sci Rep. 2022 Apr 12;12(1):6132. doi: 10.1038/s41598-022-09678-9. Sci Rep. 2022. PMID: 35413967 Free PMC article.

2

Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?

Witko-Sarsat V, Sermet-Gaudelus I, Lenoir G, Descamps-Latscha B. Witko-Sarsat V, et al. Mediators Inflamm. 1999;8(1):7-11. doi: 10.1080/09629359990658. Mediators Inflamm. 1999. PMID: 10704083 Free PMC article. Review.

3

Normal function of the cystic fibrosis conductance regulator protein can be associated with homozygous (Delta)F508 mutation.

Sermet-Gaudelus I, Vallée B, Urbin I, Torossi T, Marianovski R, Fajac A, Feuillet MN, Bresson JL, Lenoir G, Bernaudin JF, Edelman A. Sermet-Gaudelus I, et al. Pediatr Res. 2002 Nov;52(5):628-35. doi: 10.1203/00006450-200211000-00005. Pediatr Res. 2002. PMID: 12409506

4

[New therapeutic approaches to Cystic fibrosis].

Willemot JM, Sermet Gaudelus I, Lenoir G. Willemot JM, et al. Ann Pharm Fr. 2003 Jul;61(4):253-8. Ann Pharm Fr. 2003. PMID: 12843958 Review. French.

5

Evaluation of MRP1-5 gene expression in cystic fibrosis patients homozygous for the delta F508 mutation.

Hurbain I, Sermet-Gaudelus I, Vallee B, Feuillet MN, Lenoir G, Bernaudin JF, Edelman A, Fajac A. Hurbain I, et al. Pediatr Res. 2003 Nov;54(5):627-34. doi: 10.1203/01.PDR.0000090926.16166.3F. Epub 2003 Aug 20. Pediatr Res. 2003. PMID: 12930913

6

Chloride transport in nasal ciliated cells of cystic fibrosis heterozygotes.

Sermet-Gaudelus I, Déchaux M, Vallée B, Fajac A, Girodon E, Nguyen-Khoa T, Marianovski R, Hurbain I, Bresson JL, Lenoir G, Edelman A. Sermet-Gaudelus I, et al. Am J Respir Crit Care Med. 2005 May 1;171(9):1026-31. doi: 10.1164/rccm.200406-740OC. Epub 2005 Feb 11. Am J Respir Crit Care Med. 2005. PMID: 15709055

7

Down-regulation of the anti-inflammatory protein annexin A1 in cystic fibrosis knock-out mice and patients.

Bensalem N, Ventura AP, Vallée B, Lipecka J, Tondelier D, Davezac N, Dos Santos A, Perretti M, Fajac A, Sermet-Gaudelus I, Renouil M, Lesure JF, Halgand F, Laprévote O, Edelman A. Bensalem N, et al. Mol Cell Proteomics. 2005 Oct;4(10):1591-601. doi: 10.1074/mcp.M500019-MCP200. Epub 2005 Jul 12. Mol Cell Proteomics. 2005. PMID: 16014420 Free article.

8

The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.

Sermet-Gaudelus I, Roussel D, Bui S, Deneuville E, Huet F, Reix P, Bellon G, Lenoir G, Edelman A. Sermet-Gaudelus I, et al. BMC Pediatr. 2006 Oct 3;6:25. doi: 10.1186/1471-2431-6-25. BMC Pediatr. 2006. PMID: 17018149 Free PMC article.

9

In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study.

Sermet-Gaudelus I, Renouil M, Fajac A, Bidou L, Parbaille B, Pierrot S, Davy N, Bismuth E, Reinert P, Lenoir G, Lesure JF, Rousset JP, Edelman A. Sermet-Gaudelus I, et al. BMC Med. 2007 Mar 29;5:5. doi: 10.1186/1741-7015-5-5. BMC Med. 2007. PMID: 17394637 Free PMC article. Clinical Trial.

10

Genetic testing to provide targeted treatment for cystic fibrosis patients.

Edelman A, Sermet-Gaudelus I, Rousset JP. Edelman A, et al. Pharmacogenomics. 2007 Sep;8(9):1101-4. doi: 10.2217/14622416.8.9.1101. Pharmacogenomics. 2007. PMID: 17924824 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

252 results

Search Page

Filters